Drugs that contain Fulvestrant

1. Drug name - FULVESTRANT

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9833459 FRESENIUS KABI USA Fulvestrant formulations Feb, 2034

(11 years from now)

US10188663 FRESENIUS KABI USA Fulvestrant formulations Feb, 2034

(11 years from now)

US9271990 FRESENIUS KABI USA Fulvestrant formulations May, 2034

(11 years from now)

Treatment: Treatment of hormone receptor positive advanced breast cancer in postmenopausal women

Dosage: SOLUTION;INTRAMUSCULAR

More Information on Dosage
Strength Dosage Availability
250MG/5ML (50MG/ML) SOLUTION;INTRAMUSCULAR Prescription

availability in other generic markets.

Click on the highlighted region to filter.